These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 25745852)
1. Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis. Tajiri M; Okamoto M; Fujimoto K; Johkoh T; Ono J; Tominaga M; Azuma K; Kawayama T; Ohta S; Izuhara K; Hoshino T Respir Investig; 2015 Mar; 53(2):73-81. PubMed ID: 25745852 [TBL] [Abstract][Full Text] [Related]
2. The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis. Ohta S; Okamoto M; Fujimoto K; Sakamoto N; Takahashi K; Yamamoto H; Kushima H; Ishii H; Akasaka K; Ono J; Kamei A; Azuma Y; Matsumoto H; Yamaguchi Y; Aihara M; Johkoh T; Kawaguchi A; Ichiki M; Sagara H; Kadota JI; Hanaoka M; Hayashi SI; Kohno S; Hoshino T; Izuhara K; PLoS One; 2017; 12(3):e0174547. PubMed ID: 28355256 [TBL] [Abstract][Full Text] [Related]
3. A Pilot HRCT Follow-Up Study to Test the Feasibility of Predictive Efficacy of Serum Periostin in Idiopathic Pulmonary Fibrosis. Liu M; Cheng ZJ; Chen J; Li H; Xue M; Fu X; Li Y; Wang J; You C; Hu H; Wu H; Huang H; Sun B J Inflamm Res; 2024; 17():6729-6742. PubMed ID: 39345899 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease. Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987 [TBL] [Abstract][Full Text] [Related]
5. Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis. Nukui Y; Miyazaki Y; Masuo M; Okamoto T; Furusawa H; Tateishi T; Kishino M; Tateishi U; Ono J; Ohta S; Izuhara K; Inase N Allergol Int; 2019 Jul; 68(3):363-369. PubMed ID: 30871804 [TBL] [Abstract][Full Text] [Related]
7. Ability of Periostin as a New Biomarker of Idiopathic Pulmonary Fibrosis. Okamoto M; Izuhara K; Ohta S; Ono J; Hoshino T Adv Exp Med Biol; 2019; 1132():79-87. PubMed ID: 31037627 [TBL] [Abstract][Full Text] [Related]
8. The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis. Carpagnano GE; Soccio P; Scioscia G; Palladino GP; Foschino Barbaro MP; Lacedonia D Rejuvenation Res; 2021 Aug; 24(4):302-306. PubMed ID: 33749341 [TBL] [Abstract][Full Text] [Related]
10. Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis. Cameli P; Bergantini L; D'alessandro M; Vietri L; Refini RM; Pieroni M; Sestini P; Bargagli E Minerva Med; 2020 Aug; 111(4):324-329. PubMed ID: 31755669 [TBL] [Abstract][Full Text] [Related]
11. Progressive worsening of idiopathic pulmonary fibrosis. High resolution computed tomography (HRCT) study with functional correlations. Battista G; Zompatori M; Fasano L; Pacilli A; Basile B Radiol Med; 2003; 105(1-2):2-11. PubMed ID: 12700539 [TBL] [Abstract][Full Text] [Related]
12. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Okamoto M; Hoshino T; Kitasato Y; Sakazaki Y; Kawayama T; Fujimoto K; Ohshima K; Shiraishi H; Uchida M; Ono J; Ohta S; Kato S; Izuhara K; Aizawa H Eur Respir J; 2011 May; 37(5):1119-27. PubMed ID: 21177844 [TBL] [Abstract][Full Text] [Related]
13. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis. Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304 [TBL] [Abstract][Full Text] [Related]
14. [Course of idiopathic pulmonary fibrosis of the Wells grade III at presentation. Study using high-resolution computerized tomography]. Zompatori M; Fasano L; Battista G; Cavina M; Bertaccini P Radiol Med; 1997 Dec; 94(6):611-7. PubMed ID: 9524598 [TBL] [Abstract][Full Text] [Related]
15. Determinants of the prognosis of idiopathic pulmonary fibrosis. Novelli F; Tavanti L; Cini S; Aquilini F; Melosini L; Romei C; Sbragia P; Falaschi F; Celi A; Paggiaro P Eur Rev Med Pharmacol Sci; 2014; 18(6):880-6. PubMed ID: 24706314 [TBL] [Abstract][Full Text] [Related]
16. Quantitative CT analysis of honeycombing area in idiopathic pulmonary fibrosis: Correlations with pulmonary function tests. Nakagawa H; Nagatani Y; Takahashi M; Ogawa E; Tho NV; Ryujin Y; Nagao T; Nakano Y Eur J Radiol; 2016 Jan; 85(1):125-130. PubMed ID: 26724656 [TBL] [Abstract][Full Text] [Related]
17. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias. Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192 [TBL] [Abstract][Full Text] [Related]
18. Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing. Yamauchi H; Bando M; Baba T; Kataoka K; Yamada Y; Yamamoto H; Miyamoto A; Ikushima S; Johkoh T; Sakai F; Terasaki Y; Hebisawa A; Kawabata Y; Sugiyama Y; Ogura T PLoS One; 2016; 11(11):e0166168. PubMed ID: 27829068 [TBL] [Abstract][Full Text] [Related]
19. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis. Song JW; Do KH; Jang SJ; Colby TV; Han S; Kim DS Chest; 2013 May; 143(5):1422-1429. PubMed ID: 23715088 [TBL] [Abstract][Full Text] [Related]
20. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis. Kono M; Nakamura Y; Oyama Y; Mori K; Hozumi H; Karayama M; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Yamada M; Hamada E; Colby TV; Maekawa M; Suda T Respir Med; 2016 Jun; 115():46-52. PubMed ID: 27215503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]